TCL Archive New FDA Commisioner’s Top Priorities: FDAMA Implimitation, Agency’s Science January 8, 1999
TCL Archive Biotherapeutics Reports LAK/IL-2 Toxicity Reduced With Constant Infusion Of IL-2 April 17, 1987